SCHEMBL7190079

SCHEMBL7190079

CO[C@@H]1[C@H](O)[C@@H](O)[C@H](c2ccc3c(O)c(NC(=O)CCc4ccccc4)c(=O)oc3c2C)O[C@]1(C)CO

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MAP1LC3B Q9GZQ8 3/20 0.39
MAP1LC3A Q9H492 3/20 0.39
HSP90AB1 P08238 2/20 0.39
POLQ O75417 1/20 0.39
ALB P02768 1/20 0.39
HSP90AA1 P07900 1/20 0.39
KDR P35968 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
MAPT P10636 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185197 0.85 HSP90AB1 (0.40) MAP1LC3BMAP1LC3AHSP90AB1POLQALB
SCHEMBL7195469 0.82 MAP1LC3B (0.54) MAP1LC3BMAP1LC3AHSP90AB1POLQALB
SCHEMBL7195470 0.82 MAP1LC3B (0.54) MAP1LC3BMAP1LC3AHSP90AB1POLQALB
SCHEMBL7784152 0.81 LMNA (0.35) MAP1LC3BMAP1LC3AHSP90AB1POLQALB
SCHEMBL7195528 0.81 HSP90AB1 (0.36) MAP1LC3BMAP1LC3AHSP90AB1POLQALB
SCHEMBL7190176 0.81 HSP90AB1 (0.39) MAP1LC3BMAP1LC3AHSP90AB1POLQALB
SCHEMBL7608589 0.80 LMNA (0.36) MAP1LC3BMAP1LC3AHSP90AB1POLQALB
SCHEMBL6942331 0.79 LMNA (0.37) MAP1LC3BMAP1LC3AHSP90AB1POLQALB
SCHEMBL8381251 0.78 KDM4E (0.39) MAP1LC3BMAP1LC3AHSP90AB1POLQALB
SCHEMBL7612818 0.78 ALDH1A1 (0.43) MAP1LC3BMAP1LC3AHSP90AB1POLQALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579902-B1 Antibiotic; ethoxy-carbamic acid 3'-ester of N-(7-((6-deoxy-5-C-methyl-4-O- methyl-alpha-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1 -benzopyran-3-yl)-benzeneacetamide AVENTIS PHARMA S.A. (FR) 2003-06-17 US disclosed